#Qsymia
LightNews LightNews
jokainen.bsky.social
I love google
What are the brand names of amphetamines? There are several prescription amphetamine drugs, and even more brand names. The drugs and their brand names include: Amphetamine: Adzenys®, Evekeo® Amphetamine combinations: Adderall®, Dyanavel®, Mydayis® Benzphetamine: Didrex® Dextroamphetamine: Dexedrine®, Dextrostat®, Procentra®, Xelstrym®, Zenzedi® Lisdexamfetamine: Vyvanse® Methamphetamine: Desoxyn® Phentermine: Adipex®, Lomaira® Phentermine combinations: Qsymia®
October 26, 2025 at 12:03 AM
ulaval.ca
Comment un médicament contre l'épilepsie fait perdre du poids: l'effet du topiramate, contenu dans le Qsymia, sur le cerveau
Comment un médicament contre l'épilepsie fait perdre du poids
Une équipe de recherche établit comment la molécule coupe-faim contenue dans le Qsymia agit sur le cerveau
nouvelles.ulaval.ca
October 3, 2025 at 7:01 PM
vanjohn10.bsky.social
Vivus CEO John Amos dishes on what payors are considering when evaluating weight loss drug coverage.
youtu.be/wWJpytZMNCQ
#WeightLoss #DrugDevelopment #LifeSciences #Pharmaceuticals #Biotech #ObesityTreatment #Qsymia
Payor Considerations in Weight Loss
YouTube video by Unboxing Biotech
youtu.be
September 20, 2025 at 9:19 PM
drugs.com
#Topamax (topiramate) causes weight loss in 6-17% of patients taking it for seizures/migraines due to appetite suppression. While not FDA-approved for weight loss alone, it's combined with phentermine in Qsymia for obesity treatment. #Topamax
How effective is Topamax (topiramate) for weight loss?
Official answer: Key Takeaways Topamax (topiramate) has been shown to cause weight loss in adults and children when used for either...
www.drugs.com
September 17, 2025 at 4:25 PM
vanjohn10.bsky.social
Qsymia is Vivus' FDA-approved chronic weight loss management drug. Many units are sold via mail order but it is also available at certified pharmacies, now including Costco. CEO John Amos provides context.
youtu.be/cYk1begTP94
$COST
#WeightLoss
Qsymia in Costco
YouTube video by Unboxing Biotech
youtu.be
September 13, 2025 at 2:49 PM
drtimos.bsky.social
LucidQuest Views >>> Obesity Weekly News – September 9th 2025 #News #semaglutide #Tirzepatide #Orforglipron #Qsymia Comment below!
Obesity Weekly News – September 9th 2025
Obesity Updates: WHO EML GLP-1s, Orforglipron P3, Korea MOU and More Your rapid roundup of Obesity — spanning China, Korea, […] The post Obesity Weekly News – September 9th 2025 appeared first on LucidQuest Ventures.
dlvr.it
September 9, 2025 at 3:09 PM
vanjohn10.bsky.social
@VIVUSLLC’s CEO John Amos examines the challenges with high dose GLP-1 agonists where patients may not get the expected benefits shown in studies
#WeightLoss #FatLoss #FitnessJourney #Nutrition #WeightManagement #DrugDevelopment #LifeSciences #Vivus #Pharmaceuticals #Biotech #Qsymia
August 31, 2025 at 8:02 PM
lilhoodlilhippie.bsky.social
Im waiting for Qsymia to become available, its expensive even with insurance.
August 29, 2025 at 9:01 PM
vanjohn10.bsky.social
#Vivus’ CEO John Amos explores the impacts of tariffs on the pharmaceutical supply chain.
#WeightLoss #PharmaSupplyChain #DrugDistribution #HealthcareLogistics #DrugDevelopment #PharmaIndustry #LifeSciences #HealthcareSupplyChain #Pharmaceuticals #Biotech #ObesityTreatment #Qsymia #Biopharma
August 26, 2025 at 1:48 PM